CME Group Inc. is a derivatives marketplace with a market cap of $95.4 billion, operating major exchanges like the CME and CBOT. Analysts predict a profit of $2.69 per share for the fiscal third quarter of 2025, slightly up from the year before. Full-year EPS is expected to rise 8.3% to $11.11.

CME’s stock has surged 18% in the past year, outperforming the S&P 500 and XLF. Citigroup upgraded CME Group stock from “Neutral” to “Buy,” with a price target of $300. Analysts give a “Moderate Buy” rating overall, with a mean price target of $308, indicating an 11.3% upside potential.

Read more at Yahoo Finance: What to Expect From CME Group’s Report